Targeted Deletion of the Tsg101 Gene Results in Cell Cycle Arrest at G1/S and p53-independent Cell Death
Open Access
- 1 November 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (45), 43216-43223
- https://doi.org/10.1074/jbc.m207662200
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- A Putative Tumor Suppressor, TSG101, Acts as a Transcriptional Suppressor through Its Coiled-Coil DomainBiochemical and Biophysical Research Communications, 1998
- Frequent abnormalities of TSG101 transcripts in human prostate cancerOncogene, 1997
- Interlayer Porosity in Montmorillonite Intercalated with Keggin-like Cation Studied by Molecular Mechanics SimulationJournal of Molecular Modeling, 1997
- Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumoursOncogene, 1997
- TSG101 may be the prototype of a class of dominant negative ubiquitin regulatorsNature Genetics, 1997
- Absence of rearrangements in the tumour susceptibility gene TSG101 in human breast cancerNature Genetics, 1997
- RETRACTED: The TSG101 Tumor Susceptibility Gene Is Located in Chromosome 11 Band p15 and Is Mutated in Human Breast CancerCell, 1997
- Cancer Cell CyclesScience, 1996
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993